Skip to main content
. 2021 Oct 22;11:20871. doi: 10.1038/s41598-021-00150-8

Figure 3.

Figure 3

Ro-3306 and geldanamycin synergistically inhibit HCT116 cell viability through induction of apoptosis. (A) In normoxia or (B) hypoxia (0.5% O2), cells were treated with Ro-3306 and geldanamycin at the indicated concentrations for (A) 48 or (B) 72 h. (C) Sub-G1 analysis by propidium iodide staining and flow cytometry of cells treated with Ro-3306 (10 μM) and geldanamycin (1 μM) under normoxia for 48 h or under hypoxia for 72 h. (D) Western blot of PARP cleavage in cells treated with Ro-3306 or geldanamycin or both. (Ε) CellTiter-Glo analysis of cell viability in HCT116 Bax-/- cells treated at indicated concentrations under normoxia for 48 h. Statistical analysis was performed using one-way ANOVA supplemented with Dunnett test. Mean ± SD was shown. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.